	Clinical and biological relevance of objectively-defined subtle cognitive decline in Alzheimer's disease: a narrative review of neuroimaging, biomarker, and clinical progression studies. J Prev Alzheimers Dis Gonzalez AI, Martinez JE, Giudicessi A, Rowe M, Ku V, Tristão-Pereira C, He B, Malotaux V, Quiroz YT. PMID: 42155557 [PubMed - as supplied by publisher]
	Biomarkers in preclinical and early Alzheimer's disease in China: a scoping review. J Prev Alzheimers Dis Peng G, Yang Y, Wang Y, Chandekar SA, Yu J. PMID: 42155345 [PubMed - as supplied by publisher]
	Vitamin E in Alzheimer's Disease: A Perspective on Antioxidant Therapy. Curr Med Chem Bjørklund G, Izmailovich M, Glushkova N, Semenova Y. PMID: 42152670 [PubMed - as supplied by publisher]
	3-(2,4-Dimethylbenzylidene)-6-chloroindolin-2-one Alleviates Memory Impairment in D-Galactose-induced Alzheimer Like Pathology in a Mouse Model. Curr Neuropharmacol Younas S, Badshah I, Akbar K, Al-Otaibi JS, Khan H. PMID: 42152660 [PubMed - as supplied by publisher]
	Effective Amelioration of Alzheimer's Disease in Preclinical Models With Electrophilic Compounds via Nrf2 Pathway Activation. J Biochem Mol Toxicol Yuan L, Asghar MA, Zhang Y, Yang Y, Zhang X, Zhao Q. PMID: 42152586 [PubMed - indexed for MEDLINE]
	Hip Bone Marrow Adiposity as a Risk Factor for Alzheimer's Disease: Insights From Mendelian Randomization Analysis. Ann Hum Genet Shi W, Zhu Z, Wu M, Cheng W, Xu H. PMID: 42152579 [PubMed - as supplied by publisher]
	Associations of gut bacterial classes Clostridia and Deltaproteobacteria with type 2 diabetes and Alzheimer's disease: A two-sample Mendelian randomization study. Medicine (Baltimore) Gao X, Wang L. PMID: 42152315 [PubMed - indexed for MEDLINE]
	Dysregulated oligodendrocyte and myelin dynamics as an early pathological feature of neuropil degeneration in Alzheimer's disease: an ultrastructural study. Acta Neuropathol Commun Erisir A, Maher EE, Anderson Z, Chawla S, Hanley L, Zhao A, Birisik K, Toklucu ES, Keskinoz EN. PMID: 42152074 [PubMed - as supplied by publisher]
	Elevated AD biomarkers do not explain cognitive performance in a community-recruited clinical trial cohort. Alzheimers Dement Landau SM, Liu P, Harrison TM, Taggett J, Ward TJ, Murphy A, Lockhart SN, Lovato LC, Koeppe R, Farias ST, Papp KV, Snyder HM, Harvey DJ, Espeland M, Maillard P, DeCarli C, Vemuri P, Weiner M, Baker LD, Jagust WJ, U.S. POINTER Study Group and Alzheimer's Disease Neuroimaging Initiative. PMID: 42151735 [PubMed - indexed for MEDLINE]
	How does type 2 diabetes modify the risk of Alzheimer's disease? Alzheimers Dement Sutherland GT, Chen A, Nguyen-Hao HT, Mundell H, Aladyeva E, Hofer MJ, Harari O, Twigg SM. PMID: 42151730 [PubMed - indexed for MEDLINE]
	Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline. Alzheimers Dement Zhang J, Zhang J, Ding J, Zhang X, Wang Y, Wei W, Chai Y, Zhang S, Chen X. PMID: 42151696 [PubMed - indexed for MEDLINE]
	Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts. Alzheimers Dement König A, Tröger J, Mallick E, Linz N, Ritchie C, Gregory S, Hunter M, Johnson K, Benavides GS, Grau-Rivera O, Radoi A, Porta-Mas C, Köhler S, Teipel S, Hansson O, Tideman P, Wuestefeld A, Palmqvist S. PMID: 42151661 [PubMed - indexed for MEDLINE]
	Physical activity, aerobic fitness, and AD blood biomarkers: The IGNITE study. Alzheimers Dement Oberlin LE, Solis-Urra P, Sewell KR, Collins AM, Kang C, Huang H, Grove G, Wan L, Kramer AF, McAuley E, Burns JM, Hillman CH, Vidoni ED, Marsland AL, Kamboh MI, Szabo-Reed A, Rogers RJ, Morris J, Zeng X, Karikari TK, Jakicic JM, Erickson KI. PMID: 42151104 [PubMed - indexed for MEDLINE]
	Peripheral biomarkers of neuroinflammation in Alzheimer's disease and vascular dementia. Biochem Pharmacol Ouyang X, Chia RSL, Chai YL, Chong JR, Sim MA, Jo DG, Arumugam TV, Sethi G, Dawe GS, Chen CP, Lai MKP. PMID: 42150695 [PubMed - as supplied by publisher]
	Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials. JAMA Neurol Flanders MD, Caunca M, La Joie R, Schneider LS, Ackley SF. PMID: 42149605 [PubMed - as supplied by publisher]
	The Copper-Gut-Brain Axis: A Triple Inflammatory Pathway Driving Neuroinflammation in Alzheimer's Disease. Aging Dis Ambi A. PMID: 42149101 [PubMed - as supplied by publisher]
	Therapeutic Landscape of Early Symptomatic Alzheimer's Disease Translated into Everyday Practice for Geriatric Providers. Clin Interv Aging Bailey-Taylor MJ, Morrow P, Hendrix J, Galluzzi KE, Sharafsaleh G. PMID: 42148368 [PubMed - indexed for MEDLINE]
	Development of coumarin-sulfonate scaffolds for cholinesterase inhibition: experimental and computational studies toward Alzheimer's disease therapy. RSC Adv Mughal EU, Naeem N, Cheema AS, Othman GA, Sadiq A, Bayrak S, K, Hawsawi MB, Gomha SM, Almaz Z. PMID: 42148273 [PubMed]
	Anti-AÎ²3-10 monoclonal antibody 7B8 improves cognitive function and protects the blood-brain barrier in APP/PS1 mice by regulating the HMGB-1/RAGE/NF-ÎºB pathway. Front Immunol You J, Liu Q, Li X. PMID: 42148080 [PubMed - indexed for MEDLINE]
	The adaptation and evaluation of a culturally grounded lifestyle intervention to mitigate the risk of Alzheimer's disease and related dementias in Native Hawaiians and Pacific Islanders: A study protocol. SSM Ment Health Kaholokula JK, Buchwald D, MacLehose R, Look M, de Silva M, Worthington Antonio JK, Desimone K, Yoshimura S, Dillard A, Kenney M, Keali, Purdy M. PMID: 42147774 [PubMed]

Articles 1 - 20 / 70456

Page 1 of 3523



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy